Resources

This collection contains guidelines, forms and documents related to accessing sebelipase alfa under the Life Saving Drugs Program.

Specialists use this spreadsheet to report their patient's test results when reapplying for treatment under the Life Saving Drugs Program.

These guidelines contain the general, initial and ongoing eligibility requirements to access certain medications for infantile onset lysosomal acid lipase deficiency (LAL-D) under the Life Saving Drugs Program.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Infantile-onset lysosomal acid-lipase deficiency disease (LAD-D).

Treating Physicians use this application form to apply for a patient to access LSDP medication for Infantile-onset lysosomal acid-lipase deficiency disease (LAD-D) for the first time, or after a break.

These guidelines contain the general, initial and ongoing eligibility requirements to access certain medications for Gaucher disease (type 1) under the Life Saving Drugs Program.

Treating physicians use this application form to apply for a patient to access LSDP medication for Gaucher disease for the first time, or after a break.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Gaucher disease.

Specialists use this spreadsheet to report their patient's test results when reapplying for treatment under the Life Saving Drugs Program.

Arrangements for image-based prescribing implemented at the start of the COVID-19 pandemic will cease on 31 March 2023 in all settings. Electronic prescribing is now widely available in Australia and provides an option for supporting telehealth consultations and enabling supply of medicines.

Electronic prescribing was fast-tracked as part of the National Health Plan for coronavirus (COVID-19). This guide for pharmacists outlines arrangements available that will help patients receive medicines via telehealth services.

Electronic prescribing has been fast-tracked as part of the National Health Plan for coronavirus (COVID-19). This guide for prescribers outlines the temporary arrangements available now that will help patients receive medicines via telehealth services.

This fridge magnet card outlines the series of recommended vaccines available free for children aged 0 to 4 years under the National Immunisation Program.

This campaign poster encourages you to vaccinate your child.

This brochure provides information about the recommended vaccines available free for children under the National Immunisation Program.

This COVID-19 top up poster contains promotional information about booking your free booster.

This COVID-19 top up poster contains promotional information about booking your free booster.

Find video resources about the recent Top up your COVID-19 protection.

The health Service Finder is the best way to book a vaccination. Find a clinic near you that suits your needs. You can use the health Service Finder to book for yourself, your children, or someone else.

This collection contains communiques from the Culturally and Linguistically Diverse (CALD) Communities Health Advisory Group.

This communique summarises the meeting of the Culturally and Linguistically Diverse (CALD) Communities COVID-19 Health Advisory Group (Advisory Group), held on 22 March 2023.

COVID-19 infection control online training is available for health care workers in all settings. It covers the fundamentals of infection prevention and control for COVID-19.